Beta Bionics Inc.
BBNX | NASDAQ
$16.55
-$0.20 (-1.19%)
Nov 2, 2026, 10:26 AM ET · Market open
Fiscal Year Period Ending | FY 2025 Dec 31, 2025 | FY 2024 Dec 31, 2024 | FY 2023 Dec 31, 2023 | FY 2022 Dec 31, 2022 |
|---|---|---|---|---|
Cash & Equivalents | 31.58M | 30.43M | 26.57M | 27.68M |
Short-Term Investments | 187.55M | 73.14M | 70.18M | n/a |
Long-Term Investments | 45.43M | n/a | 100K | n/a |
Other Long-Term Assets | 180K | 5.3M | 121K | 193K |
Receivables | 19.89M | 12M | 4.45M | n/a |
Inventory | 21.72M | 13.32M | 1.25M | n/a |
Other Current Assets | 100K | 1.05M | 275K | 250K |
Total Current Assets | 267.91M | 132.92M | 103.62M | 28.47M |
Property-Plant & Equipment | 15.23M | 11.42M | 6.2M | 6.87M |
Goodwill & Intangibles | n/a | n/a | n/a | n/a |
Total Long-Term Assets | 60.84M | 16.72M | 6.42M | 7.06M |
Total Assets | 328.74M | 149.65M | 110.04M | 35.53M |
Account Payables | 5M | 2.85M | 1.17M | 430K |
Deferred Revenue | 1.56M | 939K | 87K | n/a |
Short-Term Debt | n/a | n/a | 1.22M | n/a |
Other Current Liabilities | 14.59M | 10.94M | 2.65M | 5.57M |
Total Current Liabilities | 30.92M | 21.15M | 10.61M | 8.87M |
Long-Term Debt | n/a | n/a | n/a | n/a |
Other Long-Term Liabilities | 1.55M | 44.9M | 37.57M | 193.53M |
Total Long-Term Liabilities | 10.21M | 52.48M | 40.83M | 196.69M |
Total Liabilities | 41.13M | 73.63M | 51.43M | 205.56M |
Total Debt | 7.3M | 7.26M | 4.22M | 4.13M |
Book Value | 287.61M | 76.01M | 58.61M | -170.03M |
Book Value Per Share | 7.10 | 1.77 | 1.37 | -3.97 |
Common Stock | 4K | 1K | 1K | 1K |
Retained Earnings | -369.94M | -296.74M | -229.66M | -185.57M |
Comprehensive Income | 403K | 65K | 137K | n/a |
Shareholders Equity | 287.61M | 76.01M | 58.61M | -170.03M |
Total Investments | 232.98M | 73.14M | 70.28M | n/a |
Add to Watchlist
Select watchlists to add or remove BBNX